GlassScriptPhysician profile
John L Wang
NPI 1861693087
$38,370.67
in general payments reported to CMS, 2019-2025
22 companies · $1,122 in 2025
The $1,122 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,626 · 2020: $477 · 2021: $16K · 2022: $4,034 · 2023: $6,755 · 2024: $673 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,300 · Food and Beverage: $2,493 · Travel and Lodging: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,300.00 |
| Food and Beverage | $2,492.74 |
| Travel and Lodging | $757.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $13,840.45 | 2019-2021 | |
| Omnilife Science, INC | $11,090.68 | 2020-2025 | Omnibotics 3.0 |
| Corin USA | $9,213.35 | 2019 | |
| Stryker Corporation | $1,795.93 | 2020-2025 | Mako, Augment Injectable, Gamma |
| Zimmer Biomet Holdings, INC. | $698.56 | 2022-2025 | Rosa, Avenir, Persona |
| Medical Device Business Services, INC. | $387.43 | 2019-2025 | Monovisc, Orthovisc, Attune |
| Depuy Synthes Sales INC. | $293.81 | 2020-2024 | Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $168.79 | 2021-2025 | Iovera, Zilretta, Exparel |
| Medacta USA, INC. | $167.73 | 2024 | |
| Uoc USA INC | $131.70 | 2025 | Uts, Conformity, U-Mii, U2 Revision Stem, Psa, Ustar, U2 Knee |
| Kuros Biosciences USA, INC | $124.00 | 2025 | Magnetos |
| Smith+Nephew, INC. | $117.32 | 2023 | Journey II, Pico 14 |
| Carbofix Orthopedics INC | $96.50 | 2019 | |
| Conformis, INC. | $72.32 | 2019 | |
| Medtronic USA, INC. | $51.08 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $34.37 | 2020-2021 | |
| Eagle Pharmaceuticals, INC. | $18.01 | 2023 | |
| Orthalign INC | $16.72 | 2021 | |
| Bioventus LLC | $15.16 | 2020 | |
| Surgalign Spine Technologies, INC. | $14.47 | 2019 | |
| Orthofix Medical, INC. | $11.42 | 2019 | |
| Pfizer INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.